Related references
Note: Only part of the references are listed.Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
Anna Kotronen et al.
DIABETES (2009)
Dysfunctional Very-Low-Density Lipoprotein Synthesis and Release Is a Key Factor in Nonalcoholic Steatohepatitis Pathogenesis
Koji Fujita et al.
HEPATOLOGY (2009)
Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice
Herve Lerat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatic Fatty Acid Composition Differs between Chronic Hepatitis C Patients with and without Steatosis
Bianca M. Arendt et al.
JOURNAL OF NUTRITION (2009)
Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity
Andreas Peter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity:: Particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients
Fredrik Karpe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans
N. Stefan et al.
DIABETOLOGIA (2008)
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
G. Targher et al.
DIABETOLOGIA (2008)
Causes and Metabolic Consequences of Fatty Liver
Norbert Stefan et al.
ENDOCRINE REVIEWS (2008)
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
N. Beraza et al.
GUT (2008)
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
Leanne Hodson et al.
PROGRESS IN LIPID RESEARCH (2008)
Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis
Makoto Miyazaki et al.
CELL METABOLISM (2007)
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
Jukka Westerbacka et al.
DIABETES (2007)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver
Nuria Morral et al.
JOURNAL OF LIPID RESEARCH (2007)
Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet
Matthew T. Flowers et al.
JOURNAL OF LIPID RESEARCH (2006)
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1
Gizem Rizki et al.
JOURNAL OF LIPID RESEARCH (2006)
Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD
Hellan Kang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance
Roger Gutierrez-Juarez et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
Herbert Tilg et al.
GASTROENTEROLOGY (2006)
Mechanisms of Disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance
Michael Roden
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men
E Warensjö et al.
DIABETOLOGIA (2005)
Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome
K Ueki et al.
HEPATOLOGY RESEARCH (2005)
Stearoyl-CoA desaturase as a new drug target for obesity treatment
A Dobrzyn et al.
OBESITY REVIEWS (2005)
Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver
P Dobrzyn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog
SP Kim et al.
DIABETES (2003)
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen
DIABETOLOGIA (2003)
Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity
JM Ntambi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss
P Cohen et al.
SCIENCE (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury
J Björkegren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1
M Miyazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
